Keep in mind, too, a dog's metabolism is very different from ours. Yes, this is good news, but we're talking about an animal that would be killed by eating too much chocolate. I'll get really excited about this once we've cured some diabetic chimps.
Since here we're dealing with a non-targeted genetherapy with a relatively well understood metabolic pathway the extension to humans will be simpler. The actual vector of getting the genes in will be challenging to convert but once we have that, we can use it for many other gene therapies.
[1] http://www.sciencenews.org/view/generic/id/348250/descriptio...
[2] http://www.nytimes.com/2013/02/12/science/testing-of-some-de...
However, if one goes into trials on mice, dogs, and other animals with the understanding that you're comparing apples to oranges, there can be a lot gained.
This approach, for instance, is something completely different than I've ever seen WRT Type 1 diabetes. It's a 180-degree approach from islet cell transplants, semi-permeable protective membranes, and immuno-suppressive drugs. As a proof of concept, I think they can probably learn a lot from it - even if they can't simply copy it to humans exactly.